Search Results
TREM2 as a target for disease modification in Alzheimer’s disease
Therapeutic targeting of TREM2 in Alzheimer’s disease
TREM2-targeted antibodies enhance microglial function in Alzheimer’s disease model
APOE TREM and Microglia in the Pathogenesis of Tau-mediated Neurodegeneration with David Holtzman MD
Unleashing the potential of microglia as a therapeutic target
Impact of TREM2 deficiency on amyloid beta plaque growth
Andrea Tenner - Inflammation as a Therapeutic Target in Alzheimer's Disease
TREM2 in Neurodegeneration and Cancer | Marco Colonna, MD
Future of tau-targeting immunotherapies in Alzheimer’s disease
Jennifer M. Pocock: Microglia, TREM2 and IPSCs
Targeting neuroinflammation: identifying new targets using transcriptomics
(2/3) The Pathology of Alzheimer's disease | Professor Michael Heneka